Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03199885 |
Recruitment Status :
Recruiting
First Posted : June 27, 2017
Last Update Posted : April 14, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Adenocarcinoma Metastatic Breast Adenocarcinoma Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Unresectable Breast Carcinoma | Drug: Atezolizumab Drug: Paclitaxel Biological: Pertuzumab Other: Placebo Administration Other: Quality-of-Life Assessment Biological: Trastuzumab | Phase 3 |


PRIMARY OBJECTIVE:
I. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will improve the progression-free survival (PFS), as assessed by investigator using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria, relative to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo in patients with newly documented HER2-positive measurable metastatic breast cancer.
SECONDARY OBJECTIVES:
I. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will improve the overall survival (OS) relative to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo.
II. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will improve the overall objective response (OR), assessed by investigator using RECIST 1.1 criteria, relative to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo.
III. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will improve PFS, OR, and/or duration of objective response assessed by retrospective blinded central review using RECIST 1.1 criteria, relative to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo.
IV. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will decrease the incidence of subsequent brain metastases in patients without known brain metastases at study entry relative to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo.
V. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will contribute to increased patient-reported fatigue in comparison to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo.
VI. To determine the utility of PD-L1 immunohistochemistry (IHC) staining as a predictive and prognostic biomarker associated with clinical response, as assessed by investigator using RECIST 1.1 criteria, to atezolizumab in combination with paclitaxel, trastuzumab, and pertuzumab.
VII. To determine the immune-related toxicity profile of the two treatment regimens.
VIII. To determine the cardiac safety profile of the two treatment regimens.
EXPLORATORY OBJECTIVES:
I. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will improve the progression-free survival and overall objective response, assessed by investigator using immune-modified RECIST (iRECIST) criteria, relative to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo.
II. To identify potential biomarkers that can predict benefit from the addition of atezolizumab in patients with newly documented HER2-positive measurable metastatic breast cancer treated with a regimen of paclitaxel, pertuzumab, and trastuzumab, and placebo.
III. To explore the toxicity profile of the two treatment regimens using patient-reported symptomatic adverse events in addition to standard adverse event reports.
IV. To determine the feasibility and added value of frequent assessment of toxicity using Patient Reported Outcomes (PRO)-Common Terminology Criteria for Adverse Events (CTCAE) with electronic(e)PRO reporting.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive pertuzumab intravenously (IV) over 30-60 minutes on days 1 and 22, trastuzumab IV over 30-90 minutes on days 1 and 22, paclitaxel IV over 60 minutes on days 1, 8, 15, 22, 29, and 36, and atezolizumab IV over 60 minutes on days 1 and 22. Cycles for pertuzumab, trastuzumab and atezolizumab repeat every 6 weeks and treatment with paclitaxel repeats every 6 weeks for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients may receive additional 3 cycles of paclitaxel in the absence of progression at the investigator's discretion.
ARM II: Patients receive pertuzumab, trastuzumab, and paclitaxel as in Arm I. Patients also receive placebo IV over 60 minutes on days 1 and 22. Cycles for pertuzumab, trastuzumab, and placebo repeat every 6 weeks and treatment with paclitaxel repeats every 6 weeks for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients may receive additional 3 cycles of paclitaxel in the absence of progression at the investigator's discretion.
After completion of study treatment, patients are followed up every 3 months for 3 years and then every 6 months for 4 years.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 600 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Care Provider, Investigator) |
Primary Purpose: | Treatment |
Official Title: | A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer |
Actual Study Start Date : | March 12, 2019 |
Estimated Primary Completion Date : | January 31, 2023 |
Estimated Study Completion Date : | January 31, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Arm I (pertuzumab, trastuzumab, paclitaxel, atezolizumab)
Patients receive pertuzumab IV over 30-60 minutes on days 1 and 22, trastuzumab IV over 30-90 minutes on days 1 and 22, paclitaxel IV over 60 minutes on days 1, 8, 15, 22, 29, and 36, and atezolizumab IV over 60 minutes on days 1 and 22. Cycles for pertuzumab, trastuzumab and atezolizumab repeat every 6 weeks and treatment with paclitaxel repeats every 6 weeks for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients may receive additional 3 cycles of paclitaxel in the absence of progression at the investigator's discretion.
|
Drug: Atezolizumab
Given IV
Other Names:
Drug: Paclitaxel Given IV
Other Names:
Biological: Pertuzumab Given IV
Other Names:
Other: Quality-of-Life Assessment Ancillary studies
Other Name: Quality of Life Assessment Biological: Trastuzumab Given IV
Other Names:
|
Active Comparator: Arm II (pertuzumab, trastuzumab, paclitaxel, placebo)
Patients receive pertuzumab, trastuzumab, and paclitaxel as in Arm I. Patients also receive placebo IV over 60 minutes on days 1 and 22. Cycles for pertuzumab, trastuzumab, and placebo repeat every 6 weeks and treatment with paclitaxel repeats every 6 weeks for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients may receive additional 3 cycles of paclitaxel in the absence of progression at the investigator's discretion.
|
Drug: Paclitaxel
Given IV
Other Names:
Biological: Pertuzumab Given IV
Other Names:
Other: Placebo Administration Given IV Other: Quality-of-Life Assessment Ancillary studies
Other Name: Quality of Life Assessment Biological: Trastuzumab Given IV
Other Names:
|
- Progression free survival [ Time Frame: The time from randomization to the first documented progressive disease assessed up to 7 years ]Will be determined using the current Response Evaluation Criteria in Solid Tumors 1.1 criteria. Analysis will be based on the intent to treat population. The stratified log-rank test will be used to compare the progression free survival between the two treatment arms with the following stratification factors: prior neoadjuvant or adjuvant therapy with trastuzumab (no prior trastuzumab; prior trastuzumab and no pertuzumab; prior trastuzumab and pertuzumab), estrogen receptor status (positive; negative), and disease sites (any visceral without brain metastasis; non-visceral only without brain metastasis; brain metastasis). The Kaplan-Meier estimates will be calculated by treatment arms. Stratified Cox proportional hazards models to estimate the hazard ratio.
- Overall survival [ Time Frame: The time from randomization to death from any cause, assessed up to 7 years ]Analysis will be based on the intent to treat population. The Kaplan-Meier estimates will be calculated by treatment arms. Stratified Cox proportional hazards models to estimate the hazard ratio.
- Overall objective response [ Time Frame: Up to 7 years ]Defined as complete response or partial response. Will be determined using Response Evaluation Criteria in Solid Tumors 1.1 criteria.
- Duration of objective response [ Time Frame: From the date of initial confirmed partial response or complete response until the date of progressive disease or death from any cause assessed up to 7 years ]Tumor responses will be based on the current Response Evaluation Criteria in Solid Tumors 1.1 criteria.
- Cumulative incidence of brain metastases [ Time Frame: The time from randomization to documentation of brain metastases, assessed up to 7 years ]Analysis will be based on the intent to treat population. The Kaplan-Meier estimates will be calculated by treatment arms. Stratified Cox proportional hazards models to estimate the hazard ratio.
- Frequency of adverse events, including late immune-related toxicities [ Time Frame: Up to 7 years ]Will be categorized using the National Cancer Institute Common Terminology Criteria for Adverse Events Version 5.0.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
- Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
-
Histologically confirmed adenocarcinoma of the breast with locally recurrent, unresectable disease or metastatic disease confirmed as described below; eligible patients include those with either:
-
De novo metastatic disease presenting without prior history of HER2-positive breast cancer:
- Diagnosis should have been made from a biopsy of a metastatic disease site, but biopsy from the breast primary or involved regional lymph nodes is acceptable if biopsy of the metastatic sites was thought to carry excessive risk for the patient
-
Locally recurrent or metastatic disease following prior therapy for early breast cancer:
- Diagnosis must have been made from the biopsy of the locally recurrent or metastatic disease
- There must be an interval of >= 6 months between completion of neoadjuvant/adjuvant HER2-targeted therapy and documentation of locally recurrent or metastatic HER2-positive disease by biopsy
-
- Patients must have measurable disease based on RECIST 1.1, as determined by the site, to be eligible
- The tumor specimen obtained at the time of diagnosis of locally recurrent or metastatic disease must have been determined to be HER2-positive based on central testing according to American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines (Wolff 2018); HER2 status will initially be assessed using a Food and Drug Administration (FDA)-cleared IHC assay; positive is defined as IHC 3+ staining intensity; if HER2 IHC results are equivocal (2+), then HER2 status will be determined using a FDA-cleared HER2 in situ hybridization (ISH) test according to ASCO/CAP guidelines; sites can send biopsy specimens for central testing which have been determined to be HER2-positive or initially equivocal by either IHC or ISH on local testing
- The tumor specimen obtained at the time of diagnosis used for HER2 testing must also have central testing for PD-L1 status; patients will be eligible irrespective of PD-L1 testing result including PD-L1 indeterminant
- The tumor specimen obtained at the time of diagnosis used for HER2 and PD-L1 testing should also have central testing for estrogen receptor (ER) and progesterone receptor (PgR) according to current ASCO/CAP guideline recommendations for hormone receptor testing; patients with < 1% ER and PgR staining by IHC will be classified as negative; if sufficient material for central confirmation of ER and PgR is unavailable, local testing results for ER and PgR may be used for eligibility
- Localized palliative radiation therapy is allowed for symptom management if completed >= 14 days prior to randomization
- Patients must have imaging of the chest/abdomen/pelvis, preferably with a computed tomography (CT) scan, and a bone scan within 4 weeks prior to randomization; (NOTE: if a patient is unable to receive CT contrast, a magnetic resonance imaging [MRI] of the abdomen/pelvis and non-contrast chest CT should be performed; positron emission tomography/computed tomography [PET/CT] is not an acceptable alternative)
- MRI of the brain (or contrast CT scan of the brain if patients are unable to undergo MRI) must be obtained in patients with symptoms suggesting possible central nervous system (CNS) metastatic disease; neuroimaging is recommended but not required in asymptomatic patients
- Absolute neutrophil count (ANC) must be >= 1200/mm^3 (within 14 days prior to randomization)
- Platelet count must be >= 100,000/mm^3 (within 14 days prior to randomization)
- Hemoglobin must be >= 8 g/dL (within 14 days prior to randomization)
- Total bilirubin must be =< 1.5 x upper limit of normal (ULN) for the lab or direct bilirubin =< ULN for patients with bilirubin levels > 1.5 x ULN (within 14 days prior to randomization)
- Aspartate aminotransferase (AST) and alanine aminotransaminase (ALT) must be =< 2.5 x ULN for the lab or =< 5 x ULN for patients with liver metastases (within 14 days prior to randomization)
- Serum creatinine =< 1.5 x ULN or measured or calculated creatinine clearance >= 50 mL/min using the Cockroft-Gault formula for patients with creatinine levels > 1.5 x ULN for the lab (within 14 days prior to randomization)
- Patients not receiving anti-coagulant therapy must have prothrombin time (PT) and international normalized ratio (INR) =< 1.5 x ULN within 14 days prior to randomization; for laboratories that do not report an ULN for the INR assay, use =< 1.5 as the value for the ULN; patients receiving anti-coagulants should have a baseline INR assessed, but the value does not affect eligibility
- A serum thyroid-stimulating hormone (TSH) and AM (morning) cortisol must be obtained within 14 days prior to randomization to obtain a baseline value; patients with abnormal TSH or AM cortisol baseline levels should be further evaluated and managed per institutional standards; asymptomatic patients who require initiation or adjustment of medication or are followed without initiating treatment based on endocrinologist's recommendations are eligible
- Left ventricular ejection fraction (LVEF) assessment must be performed within 6 weeks prior to randomization; (LVEF assessment performed by echocardiogram is preferred; however, multigated acquisition scan (MUGA) scan may be substituted based on institutional preferences); the LVEF must be >= 55% regardless of the cardiac imaging facility's lower limit of normal
- Administration of atezolizumab may have an adverse effect on pregnancy and poses a risk to the human fetus, including embryo-lethality; women of child-bearing potential and men must agree to use adequate contraception (non-hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 5 months (150 days) after the last dose of atezolizumab/placebo and 7 months after the last dose of trastuzumab and pertuzumab; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately
Exclusion Criteria:
-
Patients with known primary central nervous system (CNS) malignancy or symptomatic CNS metastases are excluded, with the following exceptions:
-
Patients with asymptomatic untreated CNS disease may be enrolled, provided all of the following criteria are met:
- Evaluable or measurable disease outside the CNS
- No metastases to brain stem, midbrain, pons, medulla, cerebellum, or within 10 mm of the optic apparatus (optic nerves and chiasm)
- No history of intracranial hemorrhage or spinal cord hemorrhage
- No ongoing requirement for dexamethasone for CNS disease; patients on a stable dose of anticonvulsants are permitted
- No neurosurgical resection or brain biopsy within 28 days prior to randomization
-
Patients with asymptomatic treated CNS metastases may be enrolled, provided all the criteria listed above are met as well as the following:
- Radiographic demonstration of improvement upon the completion of CNS directed therapy and no evidence of interim progression between the completion of CNS directed therapy and the screening radiographic study
- No stereotactic radiation or whole-brain radiation within 4 weeks prior to randomization
- Screening CNS radiographic study 4 weeks from completion of radiotherapy and 2 weeks from discontinuation of corticosteroids
-
- Known leptomeningeal carcinomatosis
- Patients with metastatic disease limited to the CNS
-
History of systemic anti-cancer therapy (e.g., chemotherapy, targeted therapy) for metastatic breast cancer (MBC) with the exception of:
- Administration of trastuzumab or lapatinib concurrently with radiation therapy for brain metastases; toxicities related to lapatinib should be =< grade 1 per the CTCAE version (v)5.0, and the lapatinib must have been completed at least 2 weeks prior to randomization
- The loading doses of trastuzumab and pertuzumab may be administered prior to randomization; patients who receive a loading dose with a trastuzumab biosimilar will not be eligible
- History of exposure to cumulative doses of doxorubicin greater than 360 mg per square meter of body-surface area or its equivalent
- Prior treatment with mTOR inhibitors or CDK 4/6 inhibitors in combination with endocrine therapy for treatment of metastatic disease
- Prior treatment with CD137 agonists or immune checkpoint-blockade therapies, including anti-CD40, anti-CTLA-4, anti-PD-1, and anti-PD-L1 therapeutic antibodies
- History of non-breast malignancies (except for in situ cancers treated only by local excision and basal cell and squamous cell carcinomas of the skin) within 5 years prior to randomization
- Uncontrolled hypertension defined as sustained systolic blood pressure (BP) > 150 mmHg or diastolic BP > 90 mmHg; (patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria)
- History of asymptomatic LVEF decline to < 40% during or after prior HER2-targeted therapy
-
Cardiac disease (history of and/or active disease) that would preclude the use of the drugs included in the treatment regimens; this includes but is not confined to:
-
Active cardiac disease
- Angina pectoris that requires the current use of anti-anginal medication;
- Ventricular arrhythmias except for benign premature ventricular contractions;
- Supraventricular and nodal arrhythmias requiring a pacemaker or not controlled with medication;
- Conduction abnormality requiring a pacemaker;
- Valvular disease with documented compromise in cardiac function; or
- Symptomatic pericarditis
-
History of cardiac disease
- Prior myocardial infarction documented by elevated cardiac enzymes or persistent regional wall abnormalities on assessment of left ventricular (LV) function;
- History of documented congestive heart failure (CHF) defined as symptomatic heart failure with an LVEF < 40%; or
- Documented cardiomyopathy
-
- Nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade 2, per the CTCAE v 5.0
- History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins
- Known hypersensitivity to biopharmaceuticals produced in Chinese hamster ovary cells or other recombinant antibodies
- Known allergy or hypersensitivity to the components of the atezolizumab formulation or to any of the study drugs or excipients, (e.g., Cremophor EL)
-
History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis
- Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible
- Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible
-
Patients with eczema, psoriasis, lichen simplex chronicus of vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis would be excluded) are permitted provided that they meet the following conditions:
- Patients with psoriasis must have a baseline ophthalmologic exam to rule out ocular manifestations
- Rash must cover less than 10% of body surface area (BSA)
- Disease is well controlled at baseline and only requiring low-potency topical steroids (e.g., hydrocortisone 2.5%, hydrocortisone butyrate 0.1%, flucinolone 0.01%, desonide 0.05%, aclometasone dipropionate 0.05%)
- No acute exacerbations of underlying conditions within the last 12 months (not requiring psoralen plus ultraviolet A radiation [PUVA], methotrexate, retinoids, biologic agents, oral calcineurin inhibitors; high potency or oral steroids)
- Treatment with systemic immunosuppressive medications (including but not limited to interferons, IL-2) within 4 weeks or 5 half-lives of the drug, whichever is longer, prior to randomization
- Treatment with systemic immunosuppressive medications (including but not limited to prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis [anti-TNF] factor agents) within 14 days prior to randomization or anticipation of need for systemic immunosuppressive medications during the study; Note: Intranasal and inhaled corticosteroids or systemic corticosteroids at doses that do not exceed 10 mg/day of prednisone or an equivalent corticosteroid are allowed
- Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy or any other form of immunosuppressive therapy within 2 weeks prior to randomization
- Active hepatitis B virus (HBV) infection, defined as having a positive hepatitis B surface antigen (HBsAg) test at screening; patients with a past or resolved HBV infection, defined as having a negative HBsAg test and a positive total hepatitis B core antibody (HBcAb) test at screening, are eligible for the study if active HBV infection is ruled out on the basis of HBV deoxyribonucleic acid (DNA) viral load per local guidelines
- Active hepatitis C virus (HCV) infection, defined as having a positive HCV antibody test at screening confirmed by a polymerase chain reaction (PCR) positive for HCV ribonucleic acid (RNA)
- Patients with clinically active tuberculosis
-
Patients known to be human immunodeficiency virus (HIV) positive are eligible if they meet the following criteria within 4 weeks prior to randomization:
- A stable regimen of highly active anti-retroviral therapy (HAART) and;
- No requirement for concurrent antibiotics or antifungal agents for the prevention of opportunistic infections; and
- A CD4 count above 250 cells/mcL and an undetectable HIV viral load on standard PCR-based tests
- Severe infection within 4 weeks prior to randomization, including but not limited to hospitalization for complications of infection, bacteremia, or severe pneumonia
- Prior allogeneic stem cell or solid organ transplantation
- Symptomatic peripheral ischemia
- History of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis or >= grade 1 pulmonary fibrosis, per the CTCAE v5.0, on screening chest CT scan
- Administration of a live, attenuated vaccine within 4 weeks prior to randomization or anticipation that such vaccine will be req

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03199885


United States, Alabama | |
University of Alabama at Birmingham Cancer Center | Recruiting |
Birmingham, Alabama, United States, 35233 | |
Contact: Site Public Contact 205-934-0220 tmyrick@uab.edu | |
Principal Investigator: Erica M. Stringer-Reasor | |
United States, Alaska | |
Katmai Oncology Group | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Krishna C. Alluri | |
United States, Arizona | |
Banner MD Anderson Cancer Center | Recruiting |
Gilbert, Arizona, United States, 85234 | |
Contact: Site Public Contact 602-747-9738 | |
Principal Investigator: Shakeela W. Bahadur | |
CTCA at Western Regional Medical Center | Recruiting |
Goodyear, Arizona, United States, 85338 | |
Contact: Site Public Contact 623-207-3000 | |
Principal Investigator: Cynthia A. Lynch | |
United States, Arkansas | |
Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro | Recruiting |
Jonesboro, Arkansas, United States, 72401 | |
Contact: Site Public Contact 870-936-7066 Emily.Carvell@bmhcc.org | |
Principal Investigator: Philip E. Lammers | |
United States, California | |
Kaiser Permanente-Anaheim | Recruiting |
Anaheim, California, United States, 92806 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser Permanente-Deer Valley Medical Center | Recruiting |
Antioch, California, United States, 94531 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Baldwin Park | Recruiting |
Baldwin Park, California, United States, 91706 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser Permanente-Bellflower | Recruiting |
Bellflower, California, United States, 90706 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Alta Bates Summit Medical Center-Herrick Campus | Recruiting |
Berkeley, California, United States, 94704 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
UC Irvine Health Cancer Center-Newport | Recruiting |
Costa Mesa, California, United States, 92627 | |
Contact: Site Public Contact 877-827-8839 | |
Principal Investigator: Ritesh Parajuli | |
City of Hope Comprehensive Cancer Center | Recruiting |
Duarte, California, United States, 91010 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Sayeh M. Lavasani | |
Kaiser Permanente Dublin | Recruiting |
Dublin, California, United States, 94568 | |
Contact: Site Public Contact 877-642-4691 | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Fontana | Recruiting |
Fontana, California, United States, 92335 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser Permanente-Fremont | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Palo Alto Medical Foundation-Fremont | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Washington Hospital | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 510-745-6433 | |
Principal Investigator: Bogdan S. Eftimie | |
Kaiser Permanente-Fresno | Recruiting |
Fresno, California, United States, 93720 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente - Harbor City | Recruiting |
Harbor City, California, United States, 90710 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser Permanente-Irvine | Recruiting |
Irvine, California, United States, 92618 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Loma Linda University Medical Center | Recruiting |
Loma Linda, California, United States, 92354 | |
Contact: Site Public Contact 909-558-4050 | |
Principal Investigator: Gayathri Nagaraj | |
Kaiser Permanente Los Angeles Medical Center | Recruiting |
Los Angeles, California, United States, 90027 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser Permanente West Los Angeles | Recruiting |
Los Angeles, California, United States, 90034 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Memorial Medical Center | Recruiting |
Modesto, California, United States, 95355 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Kaiser Permanente-Modesto | Recruiting |
Modesto, California, United States, 95356 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Palo Alto Medical Foundation-Camino Division | Recruiting |
Mountain View, California, United States, 94040 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Kaiser Permanente-Oakland | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Saint Joseph Hospital - Orange | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 714-734-6220 | |
Principal Investigator: Stavroula Otis | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 877-827-8839 ucstudy@uci.edu | |
Principal Investigator: Ritesh Parajuli | |
Palo Alto Medical Foundation Health Care | Recruiting |
Palo Alto, California, United States, 94301 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Stanford Cancer Institute Palo Alto | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu | |
Principal Investigator: Irene L. Wapnir | |
Kaiser Permanente - Panorama City | Recruiting |
Panorama City, California, United States, 91402 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser Permanente-Richmond | Recruiting |
Richmond, California, United States, 94801 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Riverside | Recruiting |
Riverside, California, United States, 92505 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser Permanente-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente Downtown Commons | Recruiting |
Sacramento, California, United States, 95814 | |
Contact: Site Public Contact 877-642-4691 kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Sutter Medical Center Sacramento | Recruiting |
Sacramento, California, United States, 95816 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Kaiser Permanente-South Sacramento | Recruiting |
Sacramento, California, United States, 95823 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-San Diego Zion | Recruiting |
San Diego, California, United States, 92120 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
California Pacific Medical Center-Pacific Campus | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Kaiser Permanente-San Francisco | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Santa Teresa-San Jose | Recruiting |
San Jose, California, United States, 95119 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente San Leandro | Recruiting |
San Leandro, California, United States, 94577 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-San Marcos | Recruiting |
San Marcos, California, United States, 92078 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
Kaiser San Rafael-Gallinas | Recruiting |
San Rafael, California, United States, 94903 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente Medical Center - Santa Clara | Recruiting |
Santa Clara, California, United States, 95051 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Palo Alto Medical Foundation-Santa Cruz | Recruiting |
Santa Cruz, California, United States, 95065 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Kaiser Permanente-Santa Rosa | Recruiting |
Santa Rosa, California, United States, 95403 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
City of Hope South Pasadena | Recruiting |
South Pasadena, California, United States, 91030 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Sayeh M. Lavasani | |
Kaiser Permanente-South San Francisco | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Stockton | Recruiting |
Stockton, California, United States, 95210 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Palo Alto Medical Foundation-Sunnyvale | Recruiting |
Sunnyvale, California, United States, 94086 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
City of Hope Upland | Recruiting |
Upland, California, United States, 91786 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Sayeh M. Lavasani | |
Kaiser Permanente Medical Center-Vacaville | Recruiting |
Vacaville, California, United States, 95688 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Vallejo | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Sutter Solano Medical Center/Cancer Center | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 415-209-2686 bernicl@sutterhealth.org | |
Principal Investigator: Edmund W. Tai | |
Kaiser Permanente-Walnut Creek | Recruiting |
Walnut Creek, California, United States, 94596 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kaiser Permanente-Woodland Hills | Recruiting |
Woodland Hills, California, United States, 91367 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Lara N. Durna | |
United States, Colorado | |
Rocky Mountain Cancer Centers-Aurora | Recruiting |
Aurora, Colorado, United States, 80012 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
University of Colorado Hospital | Recruiting |
Aurora, Colorado, United States, 80045 | |
Contact: Site Public Contact 720-848-0650 | |
Principal Investigator: Anthony D. Elias | |
UCHealth Memorial Hospital Central | Recruiting |
Colorado Springs, Colorado, United States, 80909 | |
Contact: Site Public Contact 719-365-2406 | |
Principal Investigator: Anthony D. Elias | |
Memorial Hospital North | Recruiting |
Colorado Springs, Colorado, United States, 80920 | |
Contact: Site Public Contact 719-364-6700 | |
Principal Investigator: Anthony D. Elias | |
Cancer Center of Colorado at Sloan's Lake | Recruiting |
Denver, Colorado, United States, 80204 | |
Contact: Site Public Contact 303-777-2663 | |
Principal Investigator: Chelsea D. Gawryletz | |
SCL Health Saint Joseph Hospital | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Chelsea D. Gawryletz | |
Poudre Valley Hospital | Recruiting |
Fort Collins, Colorado, United States, 80524 | |
Contact: Site Public Contact 970-297-6150 | |
Principal Investigator: Anthony D. Elias | |
Cancer Care and Hematology-Fort Collins | Recruiting |
Fort Collins, Colorado, United States, 80528 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Anthony D. Elias | |
UCHealth Greeley Hospital | Recruiting |
Greeley, Colorado, United States, 80631 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Anthony D. Elias | |
UCHealth Highlands Ranch Hospital | Recruiting |
Highlands Ranch, Colorado, United States, 80129 | |
Contact: Site Public Contact 720-848-0650 | |
Principal Investigator: Anthony D. Elias | |
Good Samaritan Medical Center | Recruiting |
Lafayette, Colorado, United States, 80026 | |
Contact: Site Public Contact 303-673-1622 | |
Principal Investigator: Chelsea D. Gawryletz | |
Rocky Mountain Cancer Centers-Littleton | Recruiting |
Littleton, Colorado, United States, 80120 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Sky Ridge | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Medical Center of the Rockies | Recruiting |
Loveland, Colorado, United States, 80538 | |
Contact: Site Public Contact 970-203-7083 | |
Principal Investigator: Anthony D. Elias | |
SCL Health Lutheran Medical Center | Recruiting |
Wheat Ridge, Colorado, United States, 80033 | |
Contact: Site Public Contact 303-777-2663 ccrp@co-cancerresearch.org | |
Principal Investigator: Chelsea D. Gawryletz | |
United States, Connecticut | |
Danbury Hospital | Recruiting |
Danbury, Connecticut, United States, 06810 | |
Contact: Site Public Contact 203-739-8074 | |
Principal Investigator: Wenli Gao | |
Yale University | Recruiting |
New Haven, Connecticut, United States, 06520 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: Wajih Zaheer Kidwai | |
Norwalk Hospital | Recruiting |
Norwalk, Connecticut, United States, 06856 | |
Contact: Site Public Contact 203-852-2996 jennifer.long@norwalkhealth.org | |
Principal Investigator: Richard C. Frank | |
United States, Delaware | |
Beebe South Coastal Health Campus | Recruiting |
Frankford, Delaware, United States, 19945 | |
Contact: Site Public Contact 302-645-3100 Dmiskin@Beebehealthcare.org | |
Principal Investigator: Gregory A. Masters | |
Helen F Graham Cancer Center | Recruiting |
Newark, Delaware, United States, 19713 | |
Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
Principal Investigator: Gregory A. Masters | |
Medical Oncology Hematology Consultants PA | Recruiting |
Newark, Delaware, United States, 19713 | |
Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
Principal Investigator: Gregory A. Masters | |
Beebe Health Campus | Recruiting |
Rehoboth Beach, Delaware, United States, 19971 | |
Contact: Site Public Contact 302-645-3100 Dmiskin@Beebehealthcare.org | |
Principal Investigator: Gregory A. Masters | |
United States, Florida | |
AdventHealth Altamonte | Recruiting |
Altamonte Springs, Florida, United States, 32701 | |
Contact: Site Public Contact 407-303-2200 | |
Principal Investigator: Carlos A. Alemany | |
AdventHealth Celebration | Recruiting |
Celebration, Florida, United States, 34747 | |
Contact: Site Public Contact 407-303-4120 | |
Principal Investigator: Carlos A. Alemany | |
UM Sylvester Comprehensive Cancer Center at Coral Gables | Recruiting |
Coral Gables, Florida, United States, 33146 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Reshma L. Mahtani | |
UM Sylvester Comprehensive Cancer Center at Deerfield Beach | Recruiting |
Deerfield Beach, Florida, United States, 33442 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Reshma L. Mahtani | |
Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Site Public Contact 954-267-7750 | |
Principal Investigator: Christopher M. Reynolds | |
Broward Health Medical Center | Recruiting |
Fort Lauderdale, Florida, United States, 33316 | |
Contact: Site Public Contact 954-355-5346 | |
Principal Investigator: Shannon B. Keating | |
Mount Sinai Medical Center | Recruiting |
Miami Beach, Florida, United States, 33140 | |
Contact: Site Public Contact 305-674-2625 yenrique@msmc.com | |
Principal Investigator: Gerard Chaaya | |
University of Miami Miller School of Medicine-Sylvester Cancer Center | Recruiting |
Miami, Florida, United States, 33136 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Reshma L. Mahtani | |
UM Sylvester Comprehensive Cancer Center at Kendall | Recruiting |
Miami, Florida, United States, 33176 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Reshma L. Mahtani | |
AdventHealth Orlando | Recruiting |
Orlando, Florida, United States, 32803 | |
Contact: Site Public Contact 407-303-2090 FH.Cancer.Research@flhosp.org | |
Principal Investigator: Carlos A. Alemany | |
Orlando Health Cancer Institute | Recruiting |
Orlando, Florida, United States, 32806 | |
Contact: Site Public Contact 321-841-7246 CancerClinicalTrials@orlandohealth.com | |
Principal Investigator: Ana E. Cuesta Fernandez | |
Sacred Heart Hospital | Active, not recruiting |
Pensacola, Florida, United States, 32504 | |
UM Sylvester Comprehensive Cancer Center at Plantation | Recruiting |
Plantation, Florida, United States, 33324 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Reshma L. Mahtani | |
Cleveland Clinic-Weston | Recruiting |
Weston, Florida, United States, 33331 | |
Contact: Site Public Contact 954-659-5705 CancerAnswer@ccf.org | |
Principal Investigator: Megan L. Kruse | |
United States, Georgia | |
Phoebe Putney Memorial Hospital | Recruiting |
Albany, Georgia, United States, 31701 | |
Contact: Site Public Contact 229-312-0405 ga_cares@augusta.edu | |
Principal Investigator: Sharad A. Ghamande | |
University Cancer and Blood Center LLC | Recruiting |
Athens, Georgia, United States, 30607 | |
Contact: Site Public Contact 706-353-5006 research@universitycancer.com | |
Principal Investigator: Sharad A. Ghamande | |
Piedmont Hospital | Recruiting |
Atlanta, Georgia, United States, 30309 | |
Contact: Site Public Contact 404-425-7943 ORS@piedmont.org | |
Principal Investigator: Trevor M. Feinstein | |
Northside Hospital | Recruiting |
Atlanta, Georgia, United States, 30342 | |
Contact: Site Public Contact 404-303-3355 ClinicalTrials@northside.com | |
Principal Investigator: Gena H. Volas-Redd | |
Augusta Oncology Associates PC-D'Antignac | Recruiting |
Augusta, Georgia, United States, 30901 | |
Contact: Site Public Contact 706-821-2944 | |
Principal Investigator: Sharad A. Ghamande | |
Augusta Oncology Associates PC-Wheeler | Recruiting |
Augusta, Georgia, United States, 30909 | |
Contact: Site Public Contact 706-736-1830 | |
Principal Investigator: Sharad A. Ghamande | |
Northside Hospital - Duluth | Recruiting |
Duluth, Georgia, United States, 30096 | |
Contact: Site Public Contact 404-303-3355 Clinical.trials@northside.com | |
Principal Investigator: Gena H. Volas-Redd | |
Piedmont Fayette Hospital | Recruiting |
Fayetteville, Georgia, United States, 30214 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Trevor M. Feinstein | |
Eisenhower Army Medical Center | Recruiting |
Fort Gordon, Georgia, United States, 30905-5650 | |
Contact: Site Public Contact 706-787-2100 | |
Principal Investigator: Ryan T. Oleszewski | |
Northside Hospital - Gwinnett | Recruiting |
Lawrenceville, Georgia, United States, 30046 | |
Contact: Site Public Contact 404-303-3355 Clinical.trials@northside.com | |
Principal Investigator: Gena H. Volas-Redd | |
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler | Recruiting |
Savannah, Georgia, United States, 31405 | |
Contact: Site Public Contact 912-819-5704 underberga@sjchs.org | |
Principal Investigator: William E. Richards | |
Suburban Hematology Oncology Associates - Snellville | Recruiting |
Snellville, Georgia, United States, 30078 | |
Contact: Site Public Contact 404-303-3355 Clinical.trials@northside.com | |
Principal Investigator: Gena H. Volas-Redd | |
United States, Hawaii | |
Hawaii Cancer Care - Savio | Suspended |
'Aiea, Hawaii, United States, 96701 | |
Pali Momi Medical Center | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-486-6000 | |
Principal Investigator: Kenneth N. Sumida | |
Hawaii Cancer Care Inc - Waterfront Plaza | Suspended |
Honolulu, Hawaii, United States, 96813 | |
Queen's Cancer Cenrer - POB I | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-532-0315 | |
Principal Investigator: Kenneth N. Sumida | |
Queen's Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-545-8548 | |
Principal Investigator: Kenneth N. Sumida | |
Straub Clinic and Hospital | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-522-4333 | |
Principal Investigator: Kenneth N. Sumida | |
Queen's Cancer Center - Kuakini | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-531-8521 | |
Principal Investigator: Kenneth N. Sumida | |
Kaiser Permanente Moanalua Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96819 | |
Contact: Site Public Contact 808-432-5195 shelley.a.clark@kp.org | |
Principal Investigator: Jennifer M. Suga | |
Kapiolani Medical Center for Women and Children | Recruiting |
Honolulu, Hawaii, United States, 96826 | |
Contact: Site Public Contact 808-983-6090 | |
Principal Investigator: Kenneth N. Sumida | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Recruiting |
Boise, Idaho, United States, 83706 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Krishna C. Alluri | |
Saint Alphonsus Cancer Care Center-Caldwell | Recruiting |
Caldwell, Idaho, United States, 83605 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Medical Center | Recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Krishna C. Alluri | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Krishna C. Alluri | |
Saint Alphonsus Medical Center-Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Krishna C. Alluri | |
Kootenai Cancer Center | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Cancer Clinic | Recruiting |
Sandpoint, Idaho, United States, 83864 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Krishna C. Alluri | |
United States, Illinois | |
Rush - Copley Medical Center | Recruiting |
Aurora, Illinois, United States, 60504 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Maria T. Grosse-Perdekamp | |
Illinois CancerCare-Bloomington | Recruiting |
Bloomington, Illinois, United States, 61704 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Canton | Recruiting |
Canton, Illinois, United States, 61520 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Carthage | Recruiting |
Carthage, Illinois, United States, 62321 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: William J. Gradishar | |
Rush University Medical Center | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-942-5498 clinical_trials@rush.edu | |
Principal Investigator: Melody A. Cobleigh | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: Oana C. Danciu | |
Carle on Vermilion | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Maria T. Grosse-Perdekamp | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Maria T. Grosse-Perdekamp | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Elmhurst Memorial Hospital | Recruiting |
Elmhurst, Illinois, United States, 60126 | |
Contact: Site Public Contact 630-758-5460 Jrohde@emhc.org | |
Principal Investigator: Joseph J. Kash | |
Illinois CancerCare-Eureka | Recruiting |
Eureka, Illinois, United States, 61530 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
NorthShore University HealthSystem-Evanston Hospital | Recruiting |
Evanston, Illinois, United States, 60201 | |
Contact: Site Public Contact 847-570-2109 | |
Principal Investigator: Poornima Saha | |
Illinois CancerCare-Galesburg | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
NorthShore University HealthSystem-Glenbrook Hospital | Recruiting |
Glenview, Illinois, United States, 60026 | |
Contact: Site Public Contact 847-570-2109 | |
Principal Investigator: Poornima Saha | |
Ingalls Memorial Hospital | Recruiting |
Harvey, Illinois, United States, 60426 | |
Contact: Site Public Contact 708-915-4673 clinicaltrials@ingalls.org | |
Principal Investigator: Mark F. Kozloff | |
NorthShore University HealthSystem-Highland Park Hospital | Recruiting |
Highland Park, Illinois, United States, 60035 | |
Contact: Site Public Contact 847-570-2109 | |
Principal Investigator: Poornima Saha | |
Joliet Oncology-Hematology Associates Limited | Recruiting |
Joliet, Illinois, United States, 60435 | |
Contact: Site Public Contact 815-730-3098 maureenc@jolietoncology.com | |
Principal Investigator: Nafisa D. Burhani | |
Illinois CancerCare-Kewanee Clinic | Recruiting |
Kewanee, Illinois, United States, 61443 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Macomb | Recruiting |
Macomb, Illinois, United States, 61455 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Maria T. Grosse-Perdekamp | |
Edward Hospital/Cancer Center | Recruiting |
Naperville, Illinois, United States, 60540 | |
Contact: Site Public Contact 630-646-6075 | |
Principal Investigator: Joseph J. Kash | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Ottawa Clinic | Recruiting |
Ottawa, Illinois, United States, 61350 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Pekin | Recruiting |
Pekin, Illinois, United States, 61554 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Edward Hospital/Cancer Center?Plainfield | Recruiting |
Plainfield, Illinois, United States, 60585 | |
Contact: Site Public Contact 630-646-6075 Cancerresearch@edward.org | |
Principal Investigator: Joseph J. Kash | |
Illinois CancerCare-Princeton | Recruiting |
Princeton, Illinois, United States, 61356 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Maria T. Grosse-Perdekamp | |
Midwestern Regional Medical Center | Recruiting |
Zion, Illinois, United States, 60099 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Eugene Ahn | |
United States, Indiana | |
The Community Hospital | Suspended |
Munster, Indiana, United States, 46321 | |
Memorial Hospital of South Bend | Recruiting |
South Bend, Indiana, United States, 46601 | |
Contact: Site Public Contact 800-284-7370 | |
Principal Investigator: Nibal Saad | |
United States, Iowa | |
Mary Greeley Medical Center | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Debra M. Prow | |
University of Iowa Healthcare Cancer Services Quad Cities | Recruiting |
Bettendorf, Iowa, United States, 52722 | |
Contact: Site Public Contact 563-355-7733 kedaprile@rccqc.com | |
Principal Investigator: Sneha D. Phadke | |
McFarland Clinic PC-Boone | Recruiting |
Boone, Iowa, United States, 50036 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Mercy Hospital | Recruiting |
Cedar Rapids, Iowa, United States, 52403 | |
Contact: Site Public Contact 319-365-4673 | |
Principal Investigator: Deborah W. Wilbur | |
Oncology Associates at Mercy Medical Center | Recruiting |
Cedar Rapids, Iowa, United States, 52403 | |
Contact: Site Public Contact 319-363-2690 | |
Principal Investigator: Deborah W. Wilbur | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Methodist Medical Center | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-6727 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Des Moines | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-282-2921 | |
Principal Investigator: Robert J. Behrens | |
Broadlawns Medical Center | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-282-2200 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
McFarland Clinic PC-Trinity Cancer Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Trinity Regional Medical Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-574-8302 | |
Principal Investigator: Robert J. Behrens | |
University of Iowa/Holden Comprehensive Cancer Center | Recruiting |
Iowa City, Iowa, United States, 52242 | |
Contact: Site Public Contact 800-237-1225 | |
Principal Investigator: Sneha D. Phadke | |
McFarland Clinic PC-Jefferson | Recruiting |
Jefferson, Iowa, United States, 50129 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Marshalltown | Recruiting |
Marshalltown, Iowa, United States, 50158 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
United States, Kansas | |
HaysMed University of Kansas Health System | Recruiting |
Hays, Kansas, United States, 67601 | |
Contact: Site Public Contact 785-623-5774 | |
Principal Investigator: Qamar J. Khan | |
University of Kansas Cancer Center-West | Suspended |
Kansas City, Kansas, United States, 66112 | |
Olathe Health Cancer Center | Recruiting |
Olathe, Kansas, United States, 66061 | |
Contact: Site Public Contact 913-355-8000 Jeni.wakefield@olathehealth.org | |
Principal Investigator: Qamar J. Khan | |
University of Kansas Cancer Center-Overland Park | Recruiting |
Overland Park, Kansas, United States, 66210 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Qamar J. Khan | |
University of Kansas Hospital-Westwood Cancer Center | Recruiting |
Westwood, Kansas, United States, 66205 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Qamar J. Khan | |
United States, Kentucky | |
Saint Elizabeth Medical Center South | Recruiting |
Edgewood, Kentucky, United States, 41017 | |
Contact: Site Public Contact 859-301-4725 gina.kavanaugh@stelizabeth.com | |
Principal Investigator: Daniel B. Flora | |
Baptist Health Lexington | Recruiting |
Lexington, Kentucky, United States, 40503 | |
Contact: Site Public Contact 859-260-6425 | |
Principal Investigator: Amy Schell | |
Saint Joseph Hospital East | Recruiting |
Lexington, Kentucky, United States, 40509 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
University of Kentucky/Markey Cancer Center | Active, not recruiting |
Lexington, Kentucky, United States, 40536 | |
Baptist Health Louisville | Recruiting |
Louisville, Kentucky, United States, 40207 | |
Contact: Site Public Contact 502-897-8592 Cbcresearch@bhsi.com | |
Principal Investigator: Amy Schell | |
United States, Louisiana | |
LSU Health Baton Rouge-North Clinic | Recruiting |
Baton Rouge, Louisiana, United States, 70805 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Louisiana Hematology Oncology Associates LLC | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Mary Bird Perkins Cancer Center | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Our Lady of the Lake Physicians Group - Medical Oncology | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Woman's Hospital | Recruiting |
Baton Rouge, Louisiana, United States, 70817 | |
Contact: Site Public Contact 225-215-1353 Clinicalreserach@marybird.com | |
Principal Investigator: David S. Hanson | |
Northshore Oncology Associates-Covington | Suspended |
Covington, Louisiana, United States, 70433 | |
Oncology Center of The South Incorporated | Suspended |
Houma, Louisiana, United States, 70360 | |
United States, Maine | |
Harold Alfond Center for Cancer Care | Recruiting |
Augusta, Maine, United States, 04330 | |
Contact: Site Public Contact 207-626-4855 | |
Principal Investigator: Peter Rubin | |
Waldo County General Hospital | Recruiting |
Belfast, Maine, United States, 04915 | |
Contact: Site Public Contact 207-338-2500 | |
Principal Investigator: Peter Rubin | |
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford | Recruiting |
Biddeford, Maine, United States, 04005 | |
Contact: Site Public Contact LLemire@mmc.org | |
Principal Investigator: Peter Rubin | |
Lafayette Family Cancer Center-EMMC | Recruiting |
Brewer, Maine, United States, 04412 | |
Contact: Site Public Contact 800-987-3005 | |
Principal Investigator: Sarah J. Sinclair | |
Penobscot Bay Medical Center | Recruiting |
Rockport, Maine, United States, 04856 | |
Contact: Site Public Contact 207-396-8670 ClinicalResearch@mmc.org | |
Principal Investigator: Peter Rubin | |
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford | Recruiting |
Sanford, Maine, United States, 04073 | |
Contact: Site Public Contact LLemire@mmc.org | |
Principal Investigator: Peter Rubin | |
Maine Medical Partners - South Portland | Recruiting |
South Portland, Maine, United States, 04106 | |
Contact: Site Public Contact 207-396-8670 ClinicalResearch@mmc.org | |
Principal Investigator: Peter Rubin | |
United States, Maryland | |
University of Maryland/Greenebaum Cancer Center | Recruiting |
Baltimore, Maryland, United States, 21201 | |
Contact: Site Public Contact 800-888-8823 | |
Principal Investigator: Paula Y. Rosenblatt | |
Greater Baltimore Medical Center | Recruiting |
Baltimore, Maryland, United States, 21204 | |
Contact: Site Public Contact 443-849-3706 | |
Principal Investigator: Robert B. Donegan | |
Saint Agnes Hospital | Recruiting |
Baltimore, Maryland, United States, 21229 | |
Contact: Site Public Contact 410-368-2910 | |
Principal Investigator: Diana H. Griffiths | |
UM Upper Chesapeake Medical Center | Recruiting |
Bel Air, Maryland, United States, 21014 | |
Contact: Site Public Contact 443-643-3010 | |
Principal Investigator: Ashkan Bahrani | |
University of Maryland Shore Medical Center at Easton | Recruiting |
Easton, Maryland, United States, 21601 | |
Contact: Site Public Contact 410-822-1000 Christina.weisenborn@umm.edu | |
Principal Investigator: Mary S. De Shields | |
FMH James M Stockman Cancer Institute | Recruiting |
Frederick, Maryland, United States, 21702 | |
Contact: Site Public Contact 301-668-7043 | |
Principal Investigator: Patrick J. Mansky | |
UM Saint Joseph Medical Center | Recruiting |
Towson, Maryland, United States, 21204 | |
Contact: Site Public Contact 410-337-4569 Jeanmarie.downing@umm.edu | |
Principal Investigator: Kimberly W. Schlesinger | |
United States, Massachusetts | |
Beverly Hospital | Recruiting |
Beverly, Massachusetts, United States, 01915 | |
Contact: Site Public Contact 978-922-3000 ext 2405 | |
Principal Investigator: Corrine L. Zarwan | |
Lahey Hospital and Medical Center | Recruiting |
Burlington, Massachusetts, United States, 01805 | |
Contact: Site Public Contact 781-744-3421 cancerclinicaltrials@lahey.org | |
Principal Investigator: Corrine L. Zarwan | |
Addison Gilbert Hospital | Recruiting |
Gloucester, Massachusetts, United States, 01930 | |
Contact: Site Public Contact 978-283-4000 ext 559 | |
Principal Investigator: Corrine L. Zarwan | |
United States, Michigan | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
University of Michigan Comprehensive Cancer Center | Recruiting |
Ann Arbor, Michigan, United States, 48109 | |
Contact: Site Public Contact 800-865-1125 | |
Principal Investigator: Erin F. Cobain | |
McLaren Cancer Institute-Bay City | Recruiting |
Bay City, Michigan, United States, 48706 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
IHA Hematology Oncology Consultants-Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
IHA Hematology Oncology Consultants-Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Caro Cancer Center | Recruiting |
Caro, Michigan, United States, 48723 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
IHA Hematology Oncology Consultants-Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Hematology Oncology Consultants-Clarkston | Suspended |
Clarkston, Michigan, United States, 48346 | |
McLaren Cancer Institute-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Newland Medical Associates-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Henry Ford Macomb Hospital-Clinton Township | Recruiting |
Clinton Township, Michigan, United States, 48038 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Haythem Y. Ali | |
Wayne State University/Karmanos Cancer Institute | Recruiting |
Detroit, Michigan, United States, 48201 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Henry Ford Hospital | Recruiting |
Detroit, Michigan, United States, 48202 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Haythem Y. Ali | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
East China Township, Michigan, United States, 48054 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Weisberg Cancer Treatment Center | Recruiting |
Farmington Hills, Michigan, United States, 48334 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Beaumont Hospital - Farmington Hills | Recruiting |
Farmington Hills, Michigan, United States, 48336 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Laura M. Nadeau | |
Genesee Cancer and Blood Disease Treatment Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Genesee Hematology Oncology PC | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
McLaren Cancer Institute-Flint | Recruiting |
Flint, Michigan, United States, 48532 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Singh and Arora Hematology Oncology PC | Recruiting |
Flint, Michigan, United States, 48532 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Academic Hematology Oncology Specialists | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Allegiance Health | Recruiting |
Jackson, Michigan, United States, 49201 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Haythem Y. Ali | |
West Michigan Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
McLaren-Greater Lansing | Recruiting |
Lansing, Michigan, United States, 48910 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Mid-Michigan Physicians-Lansing | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
McLaren Cancer Institute-Lapeer Region | Recruiting |
Lapeer, Michigan, United States, 48446 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Hope Cancer Clinic | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Mary Mercy Hospital | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Michigan Breast Specialists-Macomb Township | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Mary's Oncology/Hematology Associates of Marlette | Recruiting |
Marlette, Michigan, United States, 48453 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
McLaren Cancer Institute-Macomb | Recruiting |
Mount Clemens, Michigan, United States, 48043 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
McLaren Cancer Institute-Central Michigan | Suspended |
Mount Pleasant, Michigan, United States, 48858 | |
McLaren Cancer Institute-Northern Michigan | Recruiting |
Petoskey, Michigan, United States, 49770 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Newland Medical Associates-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
McLaren-Port Huron | Recruiting |
Port Huron, Michigan, United States, 48060 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Hadeel Assad | |
Great Lakes Cancer Management Specialists-Rochester Hills | Suspended |
Rochester Hills, Michigan, United States, 48309 | |
William Beaumont Hospital-Royal Oak | Recruiting |
Royal Oak, Michigan, United States, 48073 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Laura M. Nadeau | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Oncology Hematology Associates of Saginaw Valley PC | Recruiting |
Saginaw, Michigan, United States, 48604 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Ascension Providence Hospitals - Southfield | Recruiting |
Southfield, Michigan, United States, 48075 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Cynthia M. Vakhariya | |
Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
Sterling Heights, Michigan, United States, 48312 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Ascension Saint Joseph Hospital | Recruiting |
Tawas City, Michigan, United States, 48764 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Munson Medical Center | Recruiting |
Traverse City, Michigan, United States, 49684 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
William Beaumont Hospital - Troy | Recruiting |
Troy, Michigan, United States, 48085 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Laura M. Nadeau | |
Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Michigan Breast Specialists-Warren | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Mary's Oncology/Hematology Associates of West Branch | Recruiting |
West Branch, Michigan, United States, 48661 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Metro Health Hospital | Recruiting |
Wyoming, Michigan, United States, 49519 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
Ypsilanti, Michigan, United States, 48197 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
United States, Minnesota | |
Sanford Joe Lueken Cancer Center | Recruiting |
Bemidji, Minnesota, United States, 56601 | |
Contact: Site Public Contact 218-333-5000 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Fairview Ridges Hospital | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Essentia Health - Deer River Clinic | Recruiting |
Deer River, Minnesota, United States, 56636 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Cancer Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Essentia Health Hibbing Clinic | Recruiting |
Hibbing, Minnesota, United States, 55746 | |
Contact: Site Public Contact 218-786-3308 | |
Principal Investigator: Bret E. Friday | |
Fairview Clinics and Surgery Center Maple Grove | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Mayo Clinic in Rochester | Recruiting |
Rochester, Minnesota, United States, 55905 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Ciara C. O'Sullivan | |
Coborn Cancer Center at Saint Cloud Hospital | Recruiting |
Saint Cloud, Minnesota, United States, 56303 | |
Contact: Site Public Contact 877-229-4907 coborncancercenter@centracare.com | |
Principal Investigator: Donald J. Jurgens | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: Richard T. Zera | |
Essentia Health Sandstone | Recruiting |
Sandstone, Minnesota, United States, 55072 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Sanford Thief River Falls Medical Center | Recruiting |
Thief River Falls, Minnesota, United States, 56701 | |
Contact: Site Public Contact 605-312-3320 | |
Principal Investigator: Preston D. Steen | |
Essentia Health Virginia Clinic | Recruiting |
Virginia, Minnesota, United States, 55792 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
United States, Mississippi | |
Baptist Memorial Hospital and Cancer Center-Golden Triangle | Recruiting |
Columbus, Mississippi, United States, 39705 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Philip E. Lammers | |
Gulfport Memorial Hospital | Recruiting |
Gulfport, Mississippi, United States, 39502 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Augusto C. Ochoa | |
Baptist Memorial Hospital and Cancer Center-Desoto | Recruiting |
Southhaven, Mississippi, United States, 38671 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Philip E. Lammers | |
United States, Missouri | |
Parkland Health Center-Bonne Terre | Suspended |
Bonne Terre, Missouri, United States, 63628 | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
University of Missouri - Ellis Fischel | Active, not recruiting |
Columbia, Missouri, United States, 65212 | |
Siteman Cancer Center at West County Hospital | Active, not recruiting |
Creve Coeur, Missouri, United States, 63141 | |
Capital Region Southwest Campus | Suspended |
Jefferson City, Missouri, United States, 65109 | |
Truman Medical Centers | Recruiting |
Kansas City, Missouri, United States, 64108 | |
Contact: Site Public Contact 816-404-4375 | |
Principal Investigator: Qamar J. Khan | |
University of Kansas Cancer Center - North | Recruiting |
Kansas City, Missouri, United States, 64154 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Qamar J. Khan | |
University of Kansas Cancer Center - Lee's Summit | Recruiting |
Lee's Summit, Missouri, United States, 64064 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Qamar J. Khan | |
University of Kansas Cancer Center at North Kansas City Hospital | Recruiting |
North Kansas City, Missouri, United States, 64116 | |
Contact: Site Public Contact 913-588-3671 KUCC_Navigation@kumc.edu | |
Principal Investigator: Qamar J. Khan | |
Washington University School of Medicine | Active, not recruiting |
Saint Louis, Missouri, United States, 63110 | |
Siteman Cancer Center-South County | Active, not recruiting |
Saint Louis, Missouri, United States, 63129 | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Siteman Cancer Center at Christian Hospital | Active, not recruiting |
Saint Louis, Missouri, United States, 63136 | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Siteman Cancer Center at Saint Peters Hospital | Active, not recruiting |
Saint Peters, Missouri, United States, 63376 | |
Sainte Genevieve County Memorial Hospital | Recruiting |
Sainte Genevieve, Missouri, United States, 63670 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Missouri Baptist Sullivan Hospital | Recruiting |
Sullivan, Missouri, United States, 63080 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Missouri Baptist Outpatient Center-Sunset Hills | Recruiting |
Sunset Hills, Missouri, United States, 63127 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
United States, Montana | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kalispell Regional Medical Center | Recruiting |
Kalispell, Montana, United States, 59901 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
CHI Health Saint Francis | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Southeast Nebraska Cancer Center - 68th Street Place | Recruiting |
Lincoln, Nebraska, United States, 68516 | |
Contact: Site Public Contact 402-327-7363 research@cancerpartners.com | |
Principal Investigator: Joni A. Tilford | |
Nebraska Methodist Hospital | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-354-5144 | |
Principal Investigator: Kirsten M. Leu | |
Alegent Health Bergan Mercy Medical Center | Recruiting |
Omaha, Nebraska, United States, 68124 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Nevada | |
OptumCare Cancer Care at Charleston | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at MountainView | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Hampshire | |
New Hampshire Oncology Hematology PA-Concord | Recruiting |
Concord, New Hampshire, United States, 03301 | |
Contact: Site Public Contact 603-224-2556 | |
Principal Investigator: Douglas J. Weckstein | |
Exeter Hospital | Recruiting |
Exeter, New Hampshire, United States, 03833 | |
Contact: Site Public Contact 800-439-3837 | |
Principal Investigator: YongLi Ji | |
Dartmouth Hitchcock Medical Center | Recruiting |
Lebanon, New Hampshire, United States, 03756 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@dartmouth.edu | |
Principal Investigator: Gary N. Schwartz | |
Solinsky Center for Cancer Care | Recruiting |
Manchester, New Hampshire, United States, 03103 | |
Contact: Site Public Contact 800-339-6484 | |
Principal Investigator: Douglas J. Weckstein | |
United States, New Jersey | |
Memorial Sloan Kettering Basking Ridge | Recruiting |
Basking Ridge, New Jersey, United States, 07920 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Chau T. Dang | |
Cooper Hospital University Medical Center | Recruiting |
Camden, New Jersey, United States, 08103 | |
Contact: Site Public Contact 856-325-6757 | |
Principal Investigator: Ahmed K. Abou Hussein | |
Memorial Sloan Kettering Monmouth | Recruiting |
Middletown, New Jersey, United States, 07748 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Chau T. Dang | |
Memorial Sloan Kettering Bergen | Recruiting |
Montvale, New Jersey, United States, 07645 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Chau T. Dang | |
The Valley Hospital-Luckow Pavilion | Recruiting |
Paramus, New Jersey, United States, 07652 | |
Contact: Site Public Contact 201-634-5792 | |
Principal Investigator: Eleonora Teplinsky | |
Neurosurgeons of New Jersey-Ridgewood | Recruiting |
Ridgewood, New Jersey, United States, 07450 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Eleonora Teplinsky | |
Valley Hospital | Recruiting |
Ridgewood, New Jersey, United States, 07450 | |
Contact: Site Public Contact 201-634-5792 cparish@valleyhealth.com | |
Principal Investigator: Eleonora Teplinsky | |
Holy Name Hospital | Recruiting |
Teaneck, New Jersey, United States, 07666 | |
Contact: Site Public Contact 201-833-6312 | |
Principal Investigator: Yadyra Rivera | |
MD Anderson Cancer Center at Cooper-Voorhees | Recruiting |
Voorhees, New Jersey, United States, 08043 | |
Contact: Site Public Contact 856-325-6757 | |
Principal Investigator: Ahmed K. Abou Hussein | |
Valley Medical Group - Wayne Multispecialty Practice | Recruiting |
Wayne, New Jersey, United States, 07470 | |
Contact: Site Public Contact 201-389-0195 pkurth@valleyhealth.com | |
Principal Investigator: Eleonora Teplinsky | |
Valley Health System-Hematology/Oncology | Recruiting |
Westwood, New Jersey, United States, 07675 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Eleonora Teplinsky | |
United States, New Mexico | |
University of New Mexico Cancer Center | Recruiting |
Albuquerque, New Mexico, United States, 87102 | |
Contact: Site Public Contact 505-925-0366 LByatt@nmcca.org | |
Principal Investigator: Bernard Tawfik | |
New Mexico Oncology Hematology Consultants | Suspended |
Albuquerque, New Mexico, United States, 87109 | |
Presbyterian Kaseman Hospital | Recruiting |
Albuquerque, New Mexico, United States, 87110 | |
Contact: Site Public Contact 505-559-6113 WBurman@phs.org | |
Principal Investigator: Bernard Tawfik | |
Memorial Medical Center - Las Cruces | Recruiting |
Las Cruces, New Mexico, United States, 88011 | |
Contact: Site Public Contact 575-556-6545 Kim.Hoffman@lpnt.net | |
Principal Investigator: Bernard Tawfik | |
Presbyterian Rust Medical Center/Jorgensen Cancer Center | Recruiting |
Rio Rancho, New Mexico, United States, 87124 | |
Contact: Site Public Contact 505-559-6113 WBurman@phs.org | |
Principal Investigator: Bernard Tawfik | |
United States, New York | |
Hematology Oncology Associates of Central New York-Auburn | Recruiting |
Auburn, New York, United States, 13021 | |
Contact: Site Public Contact 315-472-7504 | |
Principal Investigator: Jeffrey J. Kirshner | |
Montefiore Medical Center-Einstein Campus | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Della F. Makower | |
Montefiore Medical Center-Weiler Hospital | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Della F. Makower | |
Montefiore Medical Center - Moses Campus | Recruiting |
Bronx, New York, United States, 10467 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Della F. Makower | |
Roswell Park Cancer Institute | Recruiting |
Buffalo, New York, United States, 14263 | |
Contact: Site Public Contact 800-767-9355 askroswell@roswellpark.org | |
Principal Investigator: Ellis G. Levine | |
Memorial Sloan Kettering Commack | Recruiting |
Commack, New York, United States, 11725 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Chau T. Dang | |
Hematology Oncology Associates of Central New York-East Syracuse | Recruiting |
East Syracuse, New York, United States, 13057 | |
Contact: Site Public Contact 315-472-7504 | |
Principal Investigator: Jeffrey J. Kirshner | |
Memorial Sloan Kettering Westchester | Recruiting |
Harrison, New York, United States, 10604 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Chau T. Dang | |
NYU Winthrop Hospital | Recruiting |
Mineola, New York, United States, 11501 | |
Contact: Site Public Contact 646-754-4624 david.wallach@nyulangone.org | |
Principal Investigator: Nina D'Abreo | |
Mount Sinai Union Square | Recruiting |
New York, New York, United States, 10003 | |
Contact: Site Public Contact 212-824-7309 CCTO@mssm.edu | |
Principal Investigator: Paula Klein | |
Mount Sinai West | Recruiting |
New York, New York, United States, 10019 | |
Contact: Site Public Contact 212-824-7309 CCTO@mssm.edu | |
Principal Investigator: Paula Klein | |
Mount Sinai Hospital | Recruiting |
New York, New York, United States, 10029 | |
Contact: Site Public Contact 212-824-7309 CCTO@mssm.edu | |
Principal Investigator: Paula Klein | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Chau T. Dang | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
Stony Brook University Medical Center | Recruiting |
Stony Brook, New York, United States, 11794 | |
Contact: Site Public Contact 800-862-2215 | |
Principal Investigator: Lea N. Baer | |
State University of New York Upstate Medical University | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Site Public Contact 315-464-5476 | |
Principal Investigator: Abirami Sivapiragasam | |
Hematology Oncology Associates of Central New York-Onondaga Hill | Recruiting |
Syracuse, New York, United States, 13215 | |
Contact: Site Public Contact 315-472-7504 | |
Principal Investigator: Jeffrey J. Kirshner | |
Memorial Sloan Kettering Nassau | Recruiting |
Uniondale, New York, United States, 11553 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Chau T. Dang | |
United States, North Carolina | |
Atrium Health Stanly/LCI-Albemarle | Recruiting |
Albemarle, North Carolina, United States, 28002 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Arielle L. Heeke | |
Randolph Hospital | Recruiting |
Asheboro, North Carolina, United States, 27203 | |
Contact: Site Public Contact 336-832-0836 vivian.sheidler@conehealth.com | |
Principal Investigator: Vinay K. Gudena | |
Mission Hospital | Active, not recruiting |
Asheville, North Carolina, United States, 28801 | |
AdventHealth Infusion Center Asheville | Recruiting |
Asheville, North Carolina, United States, 28803 | |
Contact: Site Public Contact 828-650-8037 AMBER.WHEELER@AdventHealth.com | |
Principal Investigator: Raymond Thertulien | |
Messino Cancer Centers | Recruiting |
Asheville, North Carolina, United States, 28806 | |
Contact: Site Public Contact 828-212-7021 Karen.smith@aoncology.com | |
Principal Investigator: Christopher H. Chay | |
Hope Women's Cancer Centers-Asheville | Active, not recruiting |
Asheville, North Carolina, United States, 28816 | |
Cone Health Cancer Center at Alamance Regional | Recruiting |
Burlington, North Carolina, United States, 27215 | |
Contact: Site Public Contact 336-538-7725 kaye.shoffner@conehealth.com | |
Principal Investigator: Vinay K. Gudena | |
Carolinas Medical Center/Levine Cancer Institute | Recruiting |
Charlotte, North Carolina, United States, 28203 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Arielle L. Heeke | |
Atrium Health Pineville/LCI-Pineville | Recruiting |
Charlotte, North Carolina, United States, 28210 | |
Contact: Site Public Contact 980-442-2000 | |
Principal Investigator: Arielle L. Heeke | |
Southeastern Medical Oncology Center-Clinton | Recruiting |
Clinton, North Carolina, United States, 28328 | |
Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
AdventHealth Infusion Center Haywood | Recruiting |
Clyde, North Carolina, United States, 28721 | |
Contact: Site Public Contact 828-650-8037 AMBER.WHEELER@AdventHealth.com | |
Principal Investigator: Raymond Thertulien | |
Atrium Health Cabarrus/LCI-Concord | Recruiting |
Concord, North Carolina, United States, 28025 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Arielle L. Heeke | |
Levine Cancer Institute-Gaston | Recruiting |
Gastonia, North Carolina, United States, 28054 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Arielle L. Heeke | |
Southeastern Medical Oncology Center-Goldsboro | Recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
Cone Health Cancer Center | Recruiting |
Greensboro, North Carolina, United States, 27403 | |
Contact: Site Public Contact 336-832-0821 vivian.sheidler@conehealth.com | |
Principal Investigator: Vinay K. Gudena | |
Margaret R Pardee Memorial Hospital | Recruiting |
Hendersonville, North Carolina, United States, 28791 | |
Contact: Site Public Contact 828-696-4716 karen.morris@unchealth.unc.edu | |
Principal Investigator: James E. Radford | |
AdventHealth Hendersonville | Recruiting |
Hendersonville, North Carolina, United States, 28792 | |
Contact: Site Public Contact 828-650-8037 AMBER.WHEELER@AdventHealth.com | |
Principal Investigator: Raymond Thertulien | |
Southeastern Medical Oncology Center-Jacksonville | Recruiting |
Jacksonville, North Carolina, United States, 28546 | |
Contact: Site Public Contact 910-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
Vidant Oncology-Kenansville | Recruiting |
Kenansville, North Carolina, United States, 28349 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Vidant Oncology-Kinston | Recruiting |
Kinston, North Carolina, United States, 28501 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Atrium Health Lincoln/LCI-Lincolnton | Recruiting |
Lincolnton, North Carolina, United States, 28092 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Arielle L. Heeke | |
Cone Heath Cancer Center at Mebane | Recruiting |
Mebane, North Carolina, United States, 27302 | |
Contact: Site Public Contact 919-563-1160 kaye.shoffner@conehealth.com | |
Principal Investigator: Vinay K. Gudena | |
FirstHealth of the Carolinas-Moore Regional Hospital | Recruiting |
Pinehurst, North Carolina, United States, 28374 | |
Contact: Site Public Contact 910-715-3500 jcwilliams@firsthealth.org | |
Principal Investigator: Charles S. Kuzma | |
Vidant Oncology-Richlands | Suspended |
Richlands, North Carolina, United States, 28574 | |
Nash General Hospital | Recruiting |
Rocky Mount, North Carolina, United States, 27804 | |
Contact: Site Public Contact 252-962-8947 | |
Principal Investigator: Jayadev Manikkam Umakanthan | |
Marion L Shepard Cancer Center at Vidant Beaufort Hospital | Recruiting |
Washington, North Carolina, United States, 27889 | |
Contact: Site Public Contact 252-975-4308 | |
Principal Investigator: John J. Inzerillo | |
Wake Forest University Health Sciences | Recruiting |
Winston-Salem, North Carolina, United States, 27157 | |
Contact: Susan A. Melin smelin@wakehealth.edu | |
Principal Investigator: Susan A. Melin | |
United States, North Dakota | |
Sanford Bismarck Medical Center | Recruiting |
Bismarck, North Dakota, United States, 58501 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford Broadway Medical Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford Roger Maris Cancer Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-234-6161 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
United States, Ohio | |
Summa Health System - Akron Campus | Recruiting |
Akron, Ohio, United States, 44304 | |
Contact: Site Public Contact 330-375-4221 cancerresearch@summahealth.org | |
Principal Investigator: Bradley T. Clifford | |
UHHS-Chagrin Highlands Medical Center | Recruiting |
Beachwood, Ohio, United States, 44122 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
Strecker Cancer Center-Belpre | Recruiting |
Belpre, Ohio, United States, 45714 | |
Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Cleveland Clinic Mercy Hospital | Recruiting |
Canton, Ohio, United States, 44708 | |
Contact: Site Public Contact 888-293-4673 | |
Principal Investigator: Mitchell Haut | |
Geauga Hospital | Recruiting |
Chardon, Ohio, United States, 44024 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
Adena Regional Medical Center | Recruiting |
Chillicothe, Ohio, United States, 45601 | |
Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
University of Cincinnati/Barrett Cancer Center | Recruiting |
Cincinnati, Ohio, United States, 45219 | |
Contact: Site Public Contact 513-558-4553 uchealthnews@uc.edu | |
Principal Investigator: Mahmoud Charif | |
Good Samaritan Hospital - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45220 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Case Western Reserve University | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
MetroHealth Medical Center | Recruiting |
Cleveland, Ohio, United States, 44109 | |
Contact: Site Public Contact 216-778-8526 dstrater@metrohealth.org | |
Principal Investigator: William Tse | |
Cleveland Clinic Cancer Center/Fairview Hospital | Recruiting |
Cleveland, Ohio, United States, 44111 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
Cleveland Clinic Foundation | Recruiting |
Cleveland, Ohio, United States, 44195 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
Ohio State University Comprehensive Cancer Center | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu | |
Principal Investigator: Nicole O. Williams | |
Columbus Oncology and Hematology Associates Inc | Recruiting |
Columbus, Ohio, United States, 43214 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Grant Medical Center | Recruiting |
Columbus, Ohio, United States, 43215 | |
Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
The Mark H Zangmeister Center | Recruiting |
Columbus, Ohio, United States, 43219 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Doctors Hospital | Recruiting |
Columbus, Ohio, United States, 43228 | |
Contact: Site Public Contact 614-566-3275 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Dayton Physician LLC-Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Delaware Health Center-Grady Cancer Center | Recruiting |
Delaware, Ohio, United States, 43015 | |
Contact: Site Public Contact 740-615-0227 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Mercy Cancer Center-Elyria | Suspended |
Elyria, Ohio, United States, 44035 | |
OhioHealth Mansfield Hospital | Recruiting |
Mansfield, Ohio, United States, 44903 | |
Contact: Site Public Contact 419-526-8018 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Cleveland Clinic Cancer Center Mansfield | Recruiting |
Mansfield, Ohio, United States, 44906 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
Marietta Memorial Hospital | Recruiting |
Marietta, Ohio, United States, 45750 | |
Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
OhioHealth Marion General Hospital | Recruiting |
Marion, Ohio, United States, 43302 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Hillcrest Hospital Cancer Center | Recruiting |
Mayfield Heights, Ohio, United States, 44124 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
UH Seidman Cancer Center at Lake Health Mentor Campus | Recruiting |
Mentor, Ohio, United States, 44060 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
UH Seidman Cancer Center at Southwest General Hospital | Recruiting |
Middleburg Heights, Ohio, United States, 44130 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
Licking Memorial Hospital | Recruiting |
Newark, Ohio, United States, 43055 | |
Contact: Site Public Contact 740-348-4000 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
University Hospitals Parma Medical Center | Recruiting |
Parma, Ohio, United States, 44129 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
Southern Ohio Medical Center | Recruiting |
Portsmouth, Ohio, United States, 45662 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
University Hospitals Portage Medical Center | Recruiting |
Ravenna, Ohio, United States, 44266 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
North Coast Cancer Care | Recruiting |
Sandusky, Ohio, United States, 44870 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
UH Seidman Cancer Center at Firelands Regional Medical Center | Recruiting |
Sandusky, Ohio, United States, 44870 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
Cleveland Clinic Cancer Center Strongsville | Recruiting |
Strongsville, Ohio, United States, 44136 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
ProMedica Flower Hospital | Recruiting |
Sylvania, Ohio, United States, 43560 | |
Contact: Site Public Contact 419-824-1842 | |
Principal Investigator: Feng Jiang | |
University Hospitals Sharon Health Center | Recruiting |
Wadsworth, Ohio, United States, 44281 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
South Pointe Hospital | Recruiting |
Warrensville Heights, Ohio, United States, 44122 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
University Pointe | Recruiting |
West Chester, Ohio, United States, 45069 | |
Contact: Site Public Contact clinicaltrials@ucphysicians.com | |
Principal Investigator: Mahmoud Charif | |
UH Seidman Cancer Center at Saint John Medical Center | Recruiting |
Westlake, Ohio, United States, 44145 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
UHHS-Westlake Medical Center | Recruiting |
Westlake, Ohio, United States, 44145 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Joseph Baar | |
Cleveland Clinic Wooster Family Health and Surgery Center | Recruiting |
Wooster, Ohio, United States, 44691 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Megan L. Kruse | |
Genesis Healthcare System Cancer Care Center | Recruiting |
Zanesville, Ohio, United States, 43701 | |
Contact: Site Public Contact 740-454-5232 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
United States, Oklahoma | |
Cancer Centers of Southwest Oklahoma Research | Recruiting |
Lawton, Oklahoma, United States, 73505 | |
Contact: Site Public Contact 877-231-4440 | |
Principal Investigator: Wajeeha Razaq | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Wajeeha Razaq | |
Integris Southwest Medical Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73109 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Wajeeha Razaq | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
Integris Cancer Institute of Oklahoma | Recruiting |
Oklahoma City, Oklahoma, United States, 73142 | |
Contact: Site Public Contact 405-773-6613 | |
Principal Investigator: Wajeeha Razaq | |
Cancer Treatment Centers of America | Recruiting |
Tulsa, Oklahoma, United States, 74133 | |
Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org | |
Principal Investigator: Sagun Shrestha | |
Oklahoma Cancer Specialists and Research Institute-Tulsa | Recruiting |
Tulsa, Oklahoma, United States, 74146 | |
Contact: Site Public Contact 918-505-3200 | |
Principal Investigator: Wajeeha Razaq | |
United States, Oregon | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Krishna C. Alluri | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Krishna C. Alluri | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Krishna C. Alluri | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Krishna C. Alluri | |
United States, Pennsylvania | |
Saint Luke's University Hospital-Bethlehem Campus | Recruiting |
Bethlehem, Pennsylvania, United States, 18015 | |
Contact: Site Public Contact 484-503-4151 | |
Principal Investigator: Hikaru Nakajima | |
Crozer-Keystone Regional Cancer Center at Broomall | Recruiting |
Broomall, Pennsylvania, United States, 19008 | |
Contact: Site Public Contact 610-284-8237 Jolene.garney@crozer.org | |
Principal Investigator: Nabila Chowdhury | |
Bryn Mawr Hospital | Recruiting |
Bryn Mawr, Pennsylvania, United States, 19010 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Main Line Health Center-Collegeville | Recruiting |
Collegeville, Pennsylvania, United States, 19426 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Delaware County Memorial Hospital | Recruiting |
Drexel Hill, Pennsylvania, United States, 19026 | |
Contact: Site Public Contact 610-284-8237 jolene.garney@crozer.org | |
Principal Investigator: Nabila Chowdhury | |
Saint Vincent Hospital | Recruiting |
Erie, Pennsylvania, United States, 16544 | |
Contact: Site Public Contact 814-452-5000 | |
Principal Investigator: Jane M. Raymond | |
Main Line Health Center-Exton | Recruiting |
Exton, Pennsylvania, United States, 19341 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Crozer Regional Cancer Center at Brinton Lake | Recruiting |
Glen Mills, Pennsylvania, United States, 19342 | |
Contact: Site Public Contact 610-284-8237 | |
Principal Investigator: Nabila Chowdhury | |
UPMC Pinnacle Cancer Center/Community Osteopathic Campus | Recruiting |
Harrisburg, Pennsylvania, United States, 17109 | |
Contact: Site Public Contact 717-724-6765 klitchfield@PINNACLEHEALTH.org | |
Principal Investigator: Adam M. Brufsky | |
Geisinger Medical Center-Cancer Center Hazleton | Recruiting |
Hazleton, Pennsylvania, United States, 18201 | |
Contact: Site Public Contact 570-459-2901 HemonCCTrials@geisinger.edu | |
Principal Investigator: Srilatha B. Hosur | |
Jefferson Hospital | Recruiting |
Jefferson Hills, Pennsylvania, United States, 15025 | |
Contact: Site Public Contact 412-359-3043 ddefazio@wpahs.org | |
Principal Investigator: Jane M. Raymond | |
Lancaster General Hospital | Recruiting |
Lancaster, Pennsylvania, United States, 17602 | |
Contact: Site Public Contact 717-544-5511 | |
Principal Investigator: Ami P. Jhaveri | |
Riddle Memorial Hospital | Recruiting |
Media, Pennsylvania, United States, 19063 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Forbes Hospital | Recruiting |
Monroeville, Pennsylvania, United States, 15146 | |
Contact: Site Public Contact 412-858-7746 | |
Principal Investigator: Jane M. Raymond | |
Paoli Memorial Hospital | Recruiting |
Paoli, Pennsylvania, United States, 19301 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Thomas Jefferson University Hospital | Suspended |
Philadelphia, Pennsylvania, United States, 19107 | |
Eastern Regional Medical Center | Active, not recruiting |
Philadelphia, Pennsylvania, United States, 19124 | |
Allegheny General Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15212 | |
Contact: Site Public Contact 877-284-2000 | |
Principal Investigator: Jane M. Raymond | |
West Penn Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15224 | |
Contact: Site Public Contact 412-578-5000 | |
Principal Investigator: Jane M. Raymond | |
University of Pittsburgh Cancer Institute (UPCI) | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-647-8073 | |
Principal Investigator: Adam M. Brufsky | |
Geisinger Cancer Services-Pottsville | Recruiting |
Pottsville, Pennsylvania, United States, 17901 | |
Contact: Site Public Contact 800-275-6401 HemonCCTrials@geisinger.edu | |
Principal Investigator: Srilatha B. Hosur | |
Guthrie Medical Group PC-Robert Packer Hospital | Recruiting |
Sayre, Pennsylvania, United States, 18840 | |
Contact: Site Public Contact 800-836-0388 | |
Principal Investigator: Philip A. Lowry | |
Community Medical Center | Suspended |
Scranton, Pennsylvania, United States, 18510 | |
Crozer-Chester Medical Center | Recruiting |
Upland, Pennsylvania, United States, 19013 | |
Contact: Site Public Contact 610-447-2654 colleen.kennedy@crozer.org | |
Principal Investigator: Nabila Chowdhury | |
Reading Hospital | Recruiting |
West Reading, Pennsylvania, United States, 19611 | |
Contact: Site Public Contact 610-988-9323 | |
Principal Investigator: Terrence P. Cescon | |
Wexford Health and Wellness Pavilion | Recruiting |
Wexford, Pennsylvania, United States, 15090 | |
Contact: Site Public Contact 412-359-3043 ddefazio@wpahs.org | |
Principal Investigator: Jane M. Raymond | |
Geisinger Wyoming Valley/Henry Cancer Center | Recruiting |
Wilkes-Barre, Pennsylvania, United States, 18711 | |
Contact: Site Public Contact 570-271-5251 HemonCCTrials@geisinger.edu | |
Principal Investigator: Srilatha B. Hosur | |
UPMC Susquehanna | Recruiting |
Williamsport, Pennsylvania, United States, 17701 | |
Contact: Site Public Contact 800-598-4282 | |
Principal Investigator: Adam M. Brufsky | |
Abington Memorial Hospital-Asplundh Cancer Pavilion | Recruiting |
Willow Grove, Pennsylvania, United States, 19090 | |
Contact: Site Public Contact 215-481-2402 | |
Principal Investigator: Willard G. Andrews | |
Lankenau Medical Center | Recruiting |
Wynnewood, Pennsylvania, United States, 19096 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
UPMC Memorial | Recruiting |
York, Pennsylvania, United States, 17408 | |
Contact: Site Public Contact 717-724-6760 | |
Principal Investigator: Adam M. Brufsky | |
United States, South Carolina | |
Prisma Health Cancer Institute - Spartanburg | Recruiting |
Boiling Springs, South Carolina, United States, 29316 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Medical University of South Carolina | Suspended |
Charleston, South Carolina, United States, 29425 | |
Prisma Health Cancer Institute - Easley | Recruiting |
Easley, South Carolina, United States, 29640 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Butternut | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Faris | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Eastside | Recruiting |
Greenville, South Carolina, United States, 29615 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Greer | Recruiting |
Greer, South Carolina, United States, 29650 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Gibbs Cancer Center-Pelham | Recruiting |
Greer, South Carolina, United States, 29651 | |
Contact: Site Public Contact 864-560-6104 kmertz-rivera@gibbscc.org | |
Principal Investigator: Steven W. Corso | |
Levine Cancer Institute-Rock Hill | Recruiting |
Rock Hill, South Carolina, United States, 29732 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Arielle L. Heeke | |
Prisma Health Cancer Institute - Seneca | Recruiting |
Seneca, South Carolina, United States, 29672 | |
Contact: Site Public Contact 864-522-2066 kim.williams3@prismahealth.org | |
Principal Investigator: Ki Y. Chung | |
Spartanburg Medical Center | Recruiting |
Spartanburg, South Carolina, United States, 29303 | |
Contact: Site Public Contact 864-560-6104 kmertz-rivera@gibbscc.org | |
Principal Investigator: Steven W. Corso | |
Lexington Medical Center | Recruiting |
West Columbia, South Carolina, United States, 29169 | |
Contact: Site Public Contact 803-791-2105 LMCIRB@lexhealth.org | |
Principal Investigator: Steven A. Madden | |
United States, South Dakota | |
Avera Cancer Institute-Aberdeen | Recruiting |
Aberdeen, South Dakota, United States, 57401 | |
Contact: Site Public Contact 605-622-8700 oncregulatory@avera.org | |
Principal Investigator: Jason M. Jones | |
Sanford Cancer Center Oncology Clinic | Recruiting |
Sioux Falls, South Dakota, United States, 57104 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicTrialsSF@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Avera Cancer Institute | Recruiting |
Sioux Falls, South Dakota, United States, 57105 | |
Contact: Site Public Contact 605-322-3095 OncRegulatory@avera.org | |
Principal Investigator: Jason M. Jones | |
Sanford USD Medical Center - Sioux Falls | Recruiting |
Sioux Falls, South Dakota, United States, 57117-5134 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicalTrialsSF@SanfordHealth.org | |
Principal Investigator: Preston D. Steen | |
United States, Tennessee | |
Baptist Memorial Hospital and Cancer Center-Collierville | Recruiting |
Collierville, Tennessee, United States, 38017 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Philip E. Lammers | |
Cookeville Regional Medical Center | Recruiting |
Cookeville, Tennessee, United States, 38501 | |
Contact: Site Public Contact 931-783-2714 | |
Principal Investigator: Thomas J. Summers | |
Regional Cancer Center at Indian Path Community Hospital | Recruiting |
Kingsport, Tennessee, United States, 37660 | |
Contact: Site Public Contact 423-578-8538 Justin.reynolds@balladhealth.org | |
Principal Investigator: Asheesh Shipstone | |
Thompson Cancer Survival Center | Recruiting |
Knoxville, Tennessee, United States, 37916 | |
Contact: Site Public Contact 865-331-1812 | |
Principal Investigator: David D. Chism | |
Thompson Cancer Survival Center - West | Recruiting |
Knoxville, Tennessee, United States, 37932 | |
Contact: Site Public Contact 865-331-1812 | |
Principal Investigator: David D. Chism | |
Thompson Oncology Group-Lenoir City | Recruiting |
Lenoir City, Tennessee, United States, 37772 | |
Contact: Site Public Contact 865-331-1812 | |
Principal Investigator: David D. Chism | |
Thompson Oncology Group-Maryville | Recruiting |
Maryville, Tennessee, United States, 37804 | |
Contact: Site Public Contact 865-331-1812 | |
Principal Investigator: David D. Chism | |
Baptist Memorial Hospital and Cancer Center-Memphis | Recruiting |
Memphis, Tennessee, United States, 38120 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Philip E. Lammers | |
Thompson Oncology Group-Oak Ridge | Recruiting |
Oak Ridge, Tennessee, United States, 37830 | |
Contact: Site Public Contact 865-331-1812 | |
Principal Investigator: David D. Chism | |
United States, Texas | |
Houston Methodist Hospital | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 713-790-2700 | |
Principal Investigator: Dharamvir Jain | |
M D Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 877-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Vicente Valero | |
University of Texas Health Science Center at San Antonio | Recruiting |
San Antonio, Texas, United States, 78229 | |
Contact: Site Public Contact 210-450-3800 phoresearchoffice@uthscsa.edu | |
Principal Investigator: Kate I. Lathrop | |
United States, Utah | |
Huntsman Cancer Institute/University of Utah | Active, not recruiting |
Salt Lake City, Utah, United States, 84112 | |
United States, Virginia | |
Wellmont Medical Associates-Bristol | Recruiting |
Bristol, Virginia, United States, 24201 | |
Contact: Site Public Contact 423-578-8538 justin.reynolds@wellmont.org | |
Principal Investigator: Asheesh Shipstone | |
Inova Schar Cancer Institute | Recruiting |
Fairfax, Virginia, United States, 22031 | |
Contact: Site Public Contact 703-720-5210 Stephanie.VanBebber@inova.org | |
Principal Investigator: Kathleen K. Harnden | |
Bon Secours Memorial Regional Medical Center | Recruiting |
Mechanicsville, Virginia, United States, 23116 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Saint Francis Medical Center | Recruiting |
Midlothian, Virginia, United States, 23114 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Southwest VA Regional Cancer Center | Recruiting |
Norton, Virginia, United States, 24273 | |
Contact: Site Public Contact 423-578-8538 justin.reynolds@wellmont.org | |
Principal Investigator: Asheesh Shipstone | |
Bon Secours Saint Mary's Hospital | Recruiting |
Richmond, Virginia, United States, 23226 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Virginia Cancer Institute | Recruiting |
Richmond, Virginia, United States, 23230 | |
Contact: Site Public Contact 804-287-3000 david.trent@comcast.net | |
Principal Investigator: Hetal R. Vachhani | |
VCU Massey Cancer Center at Stony Point | Recruiting |
Richmond, Virginia, United States, 23235 | |
Contact: Site Public Contact 804-628-1939 mwellons@vcu.edu | |
Principal Investigator: Hetal R. Vachhani | |
Virginia Commonwealth University/Massey Cancer Center | Recruiting |
Richmond, Virginia, United States, 23298 | |
Contact: Site Public Contact 804-628-1914 klcampbell@vcu.edu | |
Principal Investigator: Hetal R. Vachhani | |
VCU Community Memorial Health Center | Recruiting |
South Hill, Virginia, United States, 23970 | |
Contact: Site Public Contact 434-774-2442 sherman.baker@vcuhealth.org | |
Principal Investigator: Hetal R. Vachhani | |
Shenandoah Oncology PC | Recruiting |
Winchester, Virginia, United States, 22601 | |
Contact: Site Public Contact 540-662-1108 William.Houck@usoncology.com | |
Principal Investigator: Hetal R. Vachhani | |
United States, Washington | |
MultiCare Auburn Medical Center | Recruiting |
Auburn, Washington, United States, 98001 | |
Contact: Site Public Contact 253-887-9333 research@multicare.org | |
Principal Investigator: Jennifer Slim | |
Swedish Cancer Institute-Edmonds | Recruiting |
Edmonds, Washington, United States, 98026 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Krishna C. Alluri | |
Providence Regional Cancer Partnership | Recruiting |
Everett, Washington, United States, 98201 | |
Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
Principal Investigator: Krishna C. Alluri | |
MultiCare Gig Harbor Medical Park | Recruiting |
Gig Harbor, Washington, United States, 98335 | |
Contact: Site Public Contact 253-403-2394 research@multicare.org | |
Principal Investigator: Jennifer Slim | |
Swedish Cancer Institute-Issaquah | Recruiting |
Issaquah, Washington, United States, 98029 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Krishna C. Alluri | |
MultiCare Good Samaritan Hospital | Recruiting |
Puyallup, Washington, United States, 98372 | |
Contact: Site Public Contact 800-351-7955 research@multicare.org | |
Principal Investigator: Jennifer Slim | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122-4307 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Krishna C. Alluri | |
MultiCare Deaconess Cancer and Blood Specialty Center - Valley | Suspended |
Spokane Valley, Washington, United States, 99216 | |
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown | Suspended |
Spokane, Washington, United States, 99204 | |
MultiCare Deaconess Cancer and Blood Specialty Center - North | Suspended |
Spokane, Washington, United States, 99218 | |
MultiCare Tacoma General Hospital | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 253-403-3229 research@multicare.org | |
Principal Investigator: Jennifer Slim | |
United States, West Virginia | |
United Hospital Center | Recruiting |
Bridgeport, West Virginia, United States, 26330 | |
Contact: Site Public Contact 304-293-7374 cancertrialsinfo@hsc.wvu.edu | |
Principal Investigator: Sobha Kurian | |
West Virginia University Charleston Division | Recruiting |
Charleston, West Virginia, United States, 25304 | |
Contact: Site Public Contact 304-388-9944 | |
Principal Investigator: Steven J. Jubelirer | |
West Virginia University Healthcare | Recruiting |
Morgantown, West Virginia, United States, 26506 | |
Contact: Site Public Contact 304-293-7374 cancertrialsinfo@hsc.wvu.edu | |
Principal Investigator: Sobha Kurian | |
Camden Clark Medical Center | Recruiting |
Parkersburg, West Virginia, United States, 26101 | |
Contact: Site Public Contact 304-293-7374 cancertrialsinfo@hsc.wvu.edu | |
Principal Investigator: Sobha Kurian | |
United States, Wisconsin | |
Langlade Hospital and Cancer Center | Recruiting |
Antigo, Wisconsin, United States, 54409 | |
Contact: Site Public Contact 715-623-9869 Juli.Alford@aspirus.org | |
Principal Investigator: Harish G. Ahuja | |
ThedaCare Regional Cancer Center | Recruiting |
Appleton, Wisconsin, United States, 54911 | |
Contact: Site Public Contact 920-364-3605 ResearchDept@thedacare.org | |
Principal Investigator: Alexander Starr | |
Duluth Clinic Ashland | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Aurora Cancer Care-Southern Lakes VLCC | Recruiting |
Burlington, Wisconsin, United States, 53105 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Medical Center-EC Cancer Center | Recruiting |
Eau Claire, Wisconsin, United States, 54701 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Kareem H. Abdelhadi | |
Mayo Clinic Health System-Eau Claire Clinic | Recruiting |
Eau Claire, Wisconsin, United States, 54701 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Ciara C. O'Sullivan | |
Aurora Health Care Germantown Health Center | Recruiting |
Germantown, Wisconsin, United States, 53022 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Cancer Care-Grafton | Recruiting |
Grafton, Wisconsin, United States, 53024 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Saint Vincent Hospital Cancer Center Green Bay | Recruiting |
Green Bay, Wisconsin, United States, 54301 | |
Contact: Site Public Contact 920-433-8889 ewd_research_admin@hshs.org | |
Principal Investigator: Matthew L. Ryan | |
Saint Vincent Hospital Cancer Center at Saint Mary's | Recruiting |
Green Bay, Wisconsin, United States, 54303 | |
Contact: Site Public Contact 920-433-8889 ewd_research_admin@hshs.org | |
Principal Investigator: Matthew L. Ryan | |
Aurora BayCare Medical Center | Recruiting |
Green Bay, Wisconsin, United States, 54311 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Mercyhealth Hospital and Cancer Center - Janesville | Recruiting |
Janesville, Wisconsin, United States, 53548 | |
Contact: Site Public Contact 608-756-6871 oncologyclinicaltrials@mhemail.org | |
Principal Investigator: Emily G. Robinson | |
UW Cancer Center Johnson Creek | Recruiting |
Johnson Creek, Wisconsin, United States, 53038 | |
Contact: Site Public Contact 920-699-3500 lynda.persico@uwmf.wisc.edu | |
Principal Investigator: Amanda Parkes | |
Aurora Cancer Care-Kenosha South | Recruiting |
Kenosha, Wisconsin, United States, 53142 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Mayo Clinic Health System-Franciscan Healthcare | Recruiting |
La Crosse, Wisconsin, United States, 54601 | |
Contact: Site Public Contact 855-776-0015 | |
Principal Investigator: Ciara C. O'Sullivan | |
University of Wisconsin Hospital and Clinics | Recruiting |
Madison, Wisconsin, United States, 53792 | |
Contact: Site Public Contact 800-622-8922 | |
Principal Investigator: Amanda Parkes | |
Aurora Bay Area Medical Group-Marinette | Recruiting |
Marinette, Wisconsin, United States, 54143 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Saint Vincent Hospital Cancer Center at Marinette | Active, not recruiting |
Marinette, Wisconsin, United States, 54143 | |
Marshfield Medical Center-Marshfield | Recruiting |
Marshfield, Wisconsin, United States, 54449 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Kareem H. Abdelhadi | |
Aspirus Medford Hospital | Recruiting |
Medford, Wisconsin, United States, 54451 | |
Contact: Site Public Contact 715-847-2353 Beth.Knetter@aspirus.org | |
Principal Investigator: Harish G. Ahuja | |
Aurora Cancer Care-Milwaukee | Recruiting |
Milwaukee, Wisconsin, United States, 53209 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Saint Luke's Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53215 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Sinai Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53233 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Clinic-Minocqua Center | Recruiting |
Minocqua, Wisconsin, United States, 54548 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Kareem H. Abdelhadi | |
ProHealth D N Greenwald Center | Recruiting |
Mukwonago, Wisconsin, United States, 53149 | |
Contact: Site Public Contact research.institute@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
ProHealth Oconomowoc Memorial Hospital | Recruiting |
Oconomowoc, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 262-928-7878 | |
Principal Investigator: Timothy R. Wassenaar | |
Saint Vincent Hospital Cancer Center at Oconto Falls | Recruiting |
Oconto Falls, Wisconsin, United States, 54154 | |
Contact: Site Public Contact 920-433-8889 ewd_research_admin@hshs.org | |
Principal Investigator: Matthew L. Ryan | |
Vince Lombardi Cancer Clinic - Oshkosh | Recruiting |
Oshkosh, Wisconsin, United States, 54904 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora Cancer Care-Racine | Recruiting |
Racine, Wisconsin, United States, 53406 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Marshfield Medical Center-Rice Lake | Recruiting |
Rice Lake, Wisconsin, United States, 54868 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Kareem H. Abdelhadi | |
Vince Lombardi Cancer Clinic-Sheboygan | Recruiting |
Sheboygan, Wisconsin, United States, 53081 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Saint Vincent Hospital Cancer Center at Sturgeon Bay | Recruiting |
Sturgeon Bay, Wisconsin, United States, 54235-1495 | |
Contact: Site Public Contact 920-433-8889 ewd_research_admin@hshs.org | |
Principal Investigator: Matthew L. Ryan | |
Aurora Medical Center in Summit | Recruiting |
Summit, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Vince Lombardi Cancer Clinic-Two Rivers | Recruiting |
Two Rivers, Wisconsin, United States, 54241 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
ProHealth Waukesha Memorial Hospital | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-7632 | |
Principal Investigator: Timothy R. Wassenaar | |
UW Cancer Center at ProHealth Care | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-5539 Chanda.miller@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Aspirus Regional Cancer Center | Recruiting |
Wausau, Wisconsin, United States, 54401 | |
Contact: Site Public Contact 877-405-6866 | |
Principal Investigator: Harish G. Ahuja | |
Aurora Cancer Care-Milwaukee West | Recruiting |
Wauwatosa, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aurora West Allis Medical Center | Recruiting |
West Allis, Wisconsin, United States, 53227 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Rubina Qamar | |
Aspirus Cancer Care - Wisconsin Rapids | Recruiting |
Wisconsin Rapids, Wisconsin, United States, 54494 | |
Contact: Site Public Contact 715-422-7718 | |
Principal Investigator: Harish G. Ahuja | |
Canada, Alberta | |
Cross Cancer Institute | Recruiting |
Edmonton, Alberta, Canada, T6G 1Z2 | |
Contact: Site Public Contact 780-432-8500 | |
Principal Investigator: Judith Meza-Junco | |
Canada, British Columbia | |
BCCA-Vancouver Cancer Centre | Recruiting |
Vancouver, British Columbia, Canada, V5Z 4E6 | |
Contact: Site Public Contact 888-939-3333 | |
Principal Investigator: Stephen K. Chia | |
BCCA-Vancouver Island Cancer Centre | Recruiting |
Victoria, British Columbia, Canada, V8R 6V5 | |
Contact: Site Public Contact 604-877-6010 | |
Principal Investigator: Xiaolan Feng | |
Canada, New Brunswick | |
The Moncton Hospital | Recruiting |
Moncton, New Brunswick, Canada, E1C 6Z8 | |
Contact: Site Public Contact 506-857-5267 | |
Principal Investigator: Maged M. Salem | |
Canada, Newfoundland and Labrador | |
Doctor H. Bliss Murphy Cancer Centre | Recruiting |
St. John's, Newfoundland and Labrador, Canada, A1B 3V6 | |
Contact: Site Public Contact 709-777-7589 | |
Principal Investigator: Erin D. Powell | |
Canada, Ontario | |
William Osler Health System-Brampton Civic Hospital | Recruiting |
Brampton, Ontario, Canada, L6R 3J7 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: William Raskin | |
London Regional Cancer Program | Recruiting |
London, Ontario, Canada, N6A 4L6 | |
Contact: Site Public Contact 519-685-8600 | |
Principal Investigator: Phillip S. Blanchette | |
Algoma District Cancer Program Sault Area Hospital | Recruiting |
Sault Ste Marie, Ontario, Canada, P6B 0A8 | |
Contact: Site Public Contact 705-759-3434 | |
Principal Investigator: Ioannis A. Voutsadakis | |
University Health Network-Princess Margaret Hospital | Recruiting |
Toronto, Ontario, Canada, M5G 2M9 | |
Contact: Site Public Contact 416-946-4501 clinical.trials@uhn.on.ca | |
Principal Investigator: Philippe L. Bedard | |
Canada, Saskatchewan | |
Allan Blair Cancer Centre | Recruiting |
Regina, Saskatchewan, Canada, S4T 7T1 | |
Contact: Site Public Contact 306-766-2213 | |
Principal Investigator: Ayesha Bashir |
Principal Investigator: | Charles E Geyer | NRG Oncology |
Responsible Party: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT03199885 |
Other Study ID Numbers: |
NCI-2017-01119 NCI-2017-01119 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) ) NRG-BR004 ( Other Identifier: NRG Oncology ) NRG-BR004 ( Other Identifier: CTEP ) U10CA180868 ( U.S. NIH Grant/Contract ) |
First Posted: | June 27, 2017 Key Record Dates |
Last Update Posted: | April 14, 2021 |
Last Verified: | October 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page |
URL: | https://grants.nih.gov/policy/sharing.htm |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Carcinoma Breast Neoplasms Adenocarcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Neoplasms by Site Breast Diseases Skin Diseases Paclitaxel Trastuzumab Albumin-Bound Paclitaxel Atezolizumab |
Pertuzumab Antineoplastic Agents, Immunological Antibodies Immunoglobulins Antibodies, Monoclonal Antineoplastic Agents, Phytogenic Antineoplastic Agents Tubulin Modulators Antimitotic Agents Mitosis Modulators Molecular Mechanisms of Pharmacological Action Immunologic Factors Physiological Effects of Drugs |